Assessment of the phenotypic range seen in Doyne honeycomb retinal dystrophy

Archives of Ophthalmology

Volumn 115, Issue 7, 1997, Pages 904-910

  Evans, Kevin ^a   Gregory, Cheryl Y ^a   Wijesuriya, Sujeewa D ^a   Kermani, Sana ^a   Jay, Marcelle R ^a   Plant, Catherine ^a   Bird, Alan C ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 2P; CLINICAL ARTICLE; ELECTRORETINOGRAPHY; GENE LOCATION; GENETIC ANALYSIS; HUMAN; ONSET AGE; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; RETINA DYSTROPHY;

EID: 0030746371     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100160074012     Document Type: Article

References (40)

1. Piguet B, Haimovici R, Bird AC. Dominantly inherited drusen represent more than one disorder: a historical review. Eye. 1995;9:34-41.
2. Doyne RW. Peculiar condition of choroiditis occurring in several members of the same family. Trans Ophthalmol Soc UK. 1899;19:71.
3. Doyne RW. A note on family choroiditis. Trans Ophthalmol Soc U K. 1910;30: 93-95.
4. Treacher-Collins T. A pathological report on a case of Doyne's choroiditis ('honeycomb' or'family choroiditis'). Ophthalmoscope. 1913:11:537-538.
5. Mould GT. Family choroiditis. Trans Ophthalmol Soc UK. 1910:30:189-190.
6. Tree M. Familial hyaline dystrophy in the fundus oculi or Doyne's family honeycomb choroiditis. Br J Ophthalmol. 1937:21:65-91.
7. Alper MG, Alfano JA. Honeycomb colloid degeneration of the retina. Arch Ophthalmol. 1953:49:392-399.
8. Franceceschetti A, François J, Babel J. tes Hérédo-dégénérescence choriorétiennes. Paris, France: Mason; 1963:1:494-515.
9. Pearce WG. Doyne's honeycomb retinal degeneration: clinical and genetic features. BrJ Ophthalmol. 1968:52:73-78.
10. Gregory CY, Evans K, Wijesuriya S, et al. The gene responsible for autosomal dominant Doyne's honeycomb retinal dystrophy (DHRD) maps to chromosome 2p16. Hum Mol Genet. 1996;5:1055-1059.
11. Héon E, Piguet B, Munier F, et al. Linkage of autosomal dominant radial drusen (malattia leventinese) to chromosome 2p16-21. Arch Ophthalmol. 1996:114: 193-198.
12. Jay M, Plant C, Evans K, Gregory CY. Doyne's revisited. Eye. 1996:10:469-472.
13. Arden GB, Carter RM, Hogg CR, et al. A modified ERG technique and the results obtained in X-linked retinitis pigmentosa. BrJ Ophthalmol. 1981:67:419-430.
14. International Standardization Committee. Standard for clinical electroretinography. Arch Ophthalmol. 1989:107:816-819.
15. Arden GB, Barrada A, Kelsey JH. New clinical test of retinal function based upon the standing potential of the eye. BrJ Ophthalmol. 1962:46:449-467.
16. Arden GB, Gunduz K, Perry S. Colour vision testing with a computer graphics system. Clin Vis Sci. 1988:2:303-320.
17. Yu TC, Falcao-Reis F, Spileers W, Arden GB. A new screening test for preglaucomatous visual loss. Invest Ophthalmol Vis Sci. 1991:32:2779-2789.
18. Massof RW, Finklestein D. Rod sensitivity relative to cone sensitivity in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1979:18:263-272.
19. Jacobson SG, Voigt W, Parel J, et al. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology. 1986:93:1604-1611.
20. Chen JC, Fitzke FW, Pauleikhoff D, Bird AC. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci. 1992;33:334-340.
21. Ernst W, Faulkner DJ, Hogg CR, Powell DJ, Arden GB. An automated static perimeter/adaptometer using light emitting diodes. Br J Ophthalmol. 1983:67:431 442.
22. Steinmetz RL, Polkinghdrne PC, Fitzke FW, Kemp CM, Bird AC. Abnormal dark adaptation and rhodopsin kinetics in Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci. 1992:33:1633-1636.
23. Moore AT, Fitzke FW, Kemp CM, et al. Abnormal dark adaption kinetics in autosomal dominant sector retinitis pigmentosa due to rod opsin mutation. BrJOphthalmol. 1992:76:465-469.
24. von Rückmann A, Fitzke FW, Bird AC. Imaging and quantifying fundus autofluorescence in normal subjects, macular dystrophy and age-related macular degeneration with a scanning laser ophthalmoscope. Br J Ophthalmol. 1995;79: 407-412.
25. Bressler NM, Munoz B, Maguire MG, et al. Five-year incidence and disappearance of drusen and retinal pigment epithelium abnormalities: Waterman Study. Arch Ophthalmol. 1995:113:301-308.
26. Schatz H, MacDonald HR. Atrophie macular degeneration: rate of spread of geographic atrophy and visual loss. Ophthalmology. 1989:96:1541-1551.
27. Gass JDM, Jallow S, Davis B. Adult vitelliform macular detachment occurring in patients with basal laminar drusen. Am J Ophthalmol. 1985:99:445-459.
28. Klainguti R. Die tapeto-retinal degeneration im katon Tessin. Klin MonatsblAugenheilkd. 1932:89:253-254.
29. Forni S, Babel J. Etude clinique et histologique de la Malattia Leventinese: affection appartenant au groupe des dégénérescences hyalines du pôle postérieur. Ophthalmologica. 1962;143:313-322.
30. Wagner H, Klainguti R. Heredodegeneration der Papillen und Maculagegend, beobachtet im Katon Tessin (Malattia levantinese): (Ges der Äerzte in Zurich, 2101-1943.) Schweiz Med Wochenschr. 1994:74:197.
31. Piguet B, Wells JA, Palmvang IB, Wormald R, Chisholm IH, Bird AC. Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol. 1993;77:400-403.
32. Heiba IM, Elston RC, Klein BEK, Klein R. Sibling correlations and segration analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol. 1994; 11:51-67.
33. Silvestri TG, Johnson PB, Hughes AE. Is genetic predisposition an important risk factor in age-related macular disease? Eye. 1994:8:564-568.
34. Klein ML, Mauldin WM, Stoumbos VD. Heredity and age-related macular degeneration: observations in monozygotic twins. Arch Ophthalmol. 1994:112:932-937.
35. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992:99:933-943.
36. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology. 1995:102:1450-1460.
37. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995:102:205-210.
38. Tsang NC, Pent old PL, Snitch PJ, Billson F. Serum levels of antioxidants and agerelated macular degeneration. Doc Ophthalmol. 1992:81:387-400.
39. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 1994:272:1413-1420.
40. Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and agerelated macular degeneration in a population-based case-control study. Arch Ophthalmol. 1995;113:1518-1523.